2009 FDA Globalization Act Scratches Fees For Cosmetics, “Unanticipated” AEs
This article was originally published in The Rose Sheet
Executive Summary
The latest version of the FDA Globalization Act includes a number of changes beneficial to small cosmetic firms; however, the draft legislation still presents some overly burdensome requirements, according to Indie Beauty Network founder and CEO Donna Maria Coles Johnson, Esq